Startups
Generis has been offering ground-breaking technology for content / document management platforms such as Documentum, Oracle WebCenter and Alfresco since 2002.
Our flagship product is CARA - a flexible, configurable, functionally rich and fast user interface to multiple systems. CARA leverages a suite of back-end modules for configuration, watermarking, data migration and more.
Generis has over 500,000 licensed users in nearly 50 companies in industries from pharmaceutical to government, media, finance / insurance and engineering / energy.
Our flagship product is CARA - a flexible, configurable, functionally rich and fast user interface to multiple systems. CARA leverages a suite of back-end modules for configuration, watermarking, data migration and more.
Generis has over 500,000 licensed users in nearly 50 companies in industries from pharmaceutical to government, media, finance / insurance and engineering / energy.
Overview
Location
United Kingdom, England, London
Employees
11-50
Founded date
1997
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 19, 2022 | Top 10 European Biopharma Company Successfully Implements CARA™ Life Sciences Platform to Automate SDEA Management and Safety Reporting | When it comes to the setup of workflows, our platform is highly flexible. It is very smart too: CARA ‘listens’ to external systems and, based on the metadata it finds, it knows what data or content to pull into a particular workflow. LONDON... |
| Jun 17, 2022 | Generis celebrates new milestones as swathes of the global pharma industry default to CARA Life Sciences™ to manage critical data and content | Often companies come to us for one use case, but then they see everything else they could be doing via our one-user/one-licence platform and they’re like kids in a candy store. LONDON (PRWEB) June 17, 2022 Generis, the creator of CARA™, the... |
| Mar 2, 2022 | Fast-Growing German Biotech Affimed Chooses Generis CARA™ Life Science Platform for Clinical R&D Support | The CARA platform from Generis offers us unique potential to enter information and re-use it across the enterprise, without duplication of effort. LONDON (PRWEB) March 02, 2022 Affimed is a fast-growing clinical-stage immuno-oncology compan... |
| Jan 27, 2022 | Generis appoints Head of Life Sciences as CARA™ growth soars | Mark Willoughby We’re delighted to welcome Mark as Head of Life Sciences. His extensive experience gained from working within Regulatory Operations will help define the ongoing enhancements to our CARA Life Science Platform, while deepening... |
| Oct 6, 2021 | Japanese Pharmaceutical Group Kyowa Kirin Selects the Generis CARA™ Life Science Platform for Global Regulatory Correspondence Management | We are delighted to have the opportunity to work with Kyowa Kirin to bring their products to market using the CARA Life Sciences Platform to ensure consistent Health Authority communications while reducing the burden of day-to-day operation... |
Reviews 0
FAQ about Generis
When was Generis founded?
Generis was founded in 1997.
What has the press written about Generis?
Parsers VC has collected 6 articles mentioning Generis, among them “Top 10 European Biopharma Company Successfully Implements CARA™ Life Sciences Platform to Automate SDEA Management and Safety Reporting” (Jul 19, 2022) and “Generis celebrates new milestones as swathes of the global pharma industry default to CARA Life Sciences™ to manage critical data and content” (Jun 17, 2022).
Is Generis still active?
Yes, Generis is active; its latest activity on Parsers VC dates from Aug 24, 2022.